Truist raised the firm’s price target on RXO Inc. (RXO) to $20 from $18 and keeps a Buy rating on the shares. RXO is one of the best ways to gain exposure to tightening capacity and the eventual recovery in spot rates, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RXO:
- RXO Inc. price target lowered to $14 from $15 at JPMorgan
- RXO Inc. price target lowered to $21 from $23 at Morgan Stanley
- RXO, Inc. Faces Mixed Performance and Regulatory Challenges: Hold Rating with Cautious Outlook
- RXO Inc. price target raised to $12 from $10 at Susquehanna
- RXO Inc. management to meet with Benchmark